|Basis of Allotment|
is a public announcement for information purposes only and is not a prospectus
announcement and does not constitute an invitation or offer to aquire, purchase or
subscribe to securities. This is not for release, publication or distribution directly or
indirectly Outside India.
Our Company was originally incorporated as Shalby Hospital Private Limited on August 30, 2004, at Ahmedabad, Gujarat, India, as a private Limited company under the Companies Act 1956. Subsequently, our Company was converted to a public limited company, and a fresh certificate of incorporation consequent upon change of name on conversion to a public limited company was issued by the Registrar of Companies, Ahmedabad, Gujarat ("RoC") on May 15, 2006. in the name of Shalby Hospital Pubic Limited, The name of our Company was subsequently changed to Shalby Hospiiais Limited, and a fresh certificate of incorporation, consequent upon change of name was issued by the RoC on July 26, 2006 Thereafter, the name of our Company was changed to Shalby Limited, and a fresh certificate of incorporation, consequent upon change of name was issued by the RoC on February 13, 2008. For details of change in the name and Registered Office of our Company, see "History and Certain Corporate Matters" on page 178 of the Prospectus dated December 11, 2017 ("Prospectus")
Registered and Corporate Office: Opposite Karnawati
Club, Sarkhej Gandhinagar Highway, Near Prahlad Nagar Garden, Ahmedabad - 380 015.
OUR PROMOTERS: DR VIKRAM SHAH, DR DARSHINI SHAH, SHANAY SHAH, ZODIAC MEDIQUIP LIMITED AND SHAH FAMILY TRUST
Our Company has filed the Prospectus dated December 11, 2017 with the Registrar of Companies, Gujarat at Ahmedabad and the Equity Shares are proposed to be listed on BSE Limited ("BSE") and National Stock Exchange of India Limited ("NSE") and the trading is expected to commence on December 15,2017.
BASIS OF ALLOTMENT
INITIAL PUBLIC OFFERING OF 20,354,838 EQUITY SHARES OF FACE VALU E OF RS 10 EACH ("EQUITY SHARES") OF SHALBY LIMITED ("COMPANY" OR "ISSUER") FOR CASH AT A PRICE OF RS 248 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS 238 PER EQUITY SHARE) AGGREGATING UPTO RS 5,048.00 MILLION ("OFFER") COMPRISING A FRESH ISSUE OF 19,354,838 EQUITY SHARES AGGREGATING UP TO RS 4,800.00 MILLION ("FRESH ISSUE"') AND AN OFFER FOR SALE OF 1,000,000 EQUITY SHARES BY DR VIKRAM SHAH (THE "SELLING SHAREHOLDER") AGGREGATING UP TO RS 248 MILLION ("OFFER FOR SALE"), THE OFFER COMPRISES A NET OFFER TO THE PUBLIC OF 20,233,838 EQUITY SHARES (THE "NET OFFER") AND A RESERVATION OF 121,000 EQUITY SHARES AGGREGATING UPTO RS 30.01 MILLION FOR SUBSCRIPTION BY ELIGIBLE EMPLOYEES (THE "EMPLOYEE RESERVATION PORTION"). THE OFFER WILL CONSTITUTE 18.85% OF OUR POST-OFFER PAID-UP EQUITY SHARE CAPITAL AND THE NET OFFER WILL CONSTITUTE 18.73% OF OUR POST-OFFER PAID-UP EQUITY SHARE CAPITAL.
Offer Price: Rs 248 per Equity Share of face value of Rs 10 each
Risks to Investors:
i. The three Book Running Lead Managers ("BRLMs")
associated with the Offer have
* The average cost of acquisition of Equity Shares held by the Selling Shareholder has beeen calculated by considering the total cost of Equity Shares held divided by the total number of Equity Shares held (including bonus shares for which the Selling Shareholder has not paid any monies). Further the total number of Equity Shares held by the selling shareholder is calculated after taking into account the number of Equity Shares transferred by or to the Selling Shareholder as applicable.
OFFER PERIOD: OPENED ON: TUESDAY, DECEMBER 5, 2017
In terms of Rule 19(2)(b) of the securities Contracts (Regulation) Rules, 1957 as amended (the "$CRR"), and in compliance with Regulation 26(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, as amended ("'SEBI ICDR Regulations"), this was an Offer wherein not more than 50% of the Net Offer shall be allocated on a proportionate basis to qualified institutional buyers ("QIBs"). Our Company/ and the Selling Shareholder, in consultation with the BRLMs, allocated 60% of the QIB Portion to Anchor Investors ("Anchor Investor Portion") on a discretionary basis, out of which, at least one-third was available for allocation to domestic Mulual Funds, valid Bids having been received from domestic Mutual Funds at or above- the Anchor Investor Allocation Price. Such number of Equity Shares representing 5% of the Net QIB Portion was available for allocation on a proportionate basis to Mutual Funds only, and the remaining Net QlB Portion was available for allocation on a proportionate basis to all QIBs (other than Anchor Investors}, including Mutual Funds, subject to valid Bids being received at or above Offer Price. Further, not less than 15% of the Net Offer was available for allocation on a proportionate basis to Non-Institutional Investors, and not less than 35% of the Net Offer was available for allocation to Retail Individual Investors in accordance with the SEBl ICDR Regulations, subject to valid Bids being received from them at or above the Offer Price. Further 121,000 Equity Shares was available for allocation on a proportionate basis to Eligible Employees, subject to valid Bids being received from them at or above the Offer Price. All Investors (except Anchor Investors) were mandatorily required to participate in this Offer only through the Application Supported by Blocked Amount ("ASBA") process, further details, see "offer provrdure" on page 426 of the Prospectus.
The Offer received 304,068 applications for 46,229,160 Equity Shares (before technical rejections) resulting 2.27 times subscription. The details of the applications received in the Offer from various categories are as under: (before technical rejections):
The Basis of Allotment was finalized in consultation with designated stock exchange NSE on December 12, 2017.
A. Allotment to Retail Individual Investors (after technical rejections)
Includes spill over of 721,970 Equity Shares from NIB Category
B. Allotment to Non-Institutional Investors (after technical rejections)
Unsubscribed portion of 1,753,356 Equity Shares spilled over to QIB and Retail Categories in the ratio of 50:35 (i.e. 1,031,386 Equity Shares spiiled over to QIB category and 721,970 Equity Shares spilled over to Retail Category)
C. Allotment under Employees Reservation Portion (after Technical Rejections)
The category-wise details of the Basis of Allotment for Employee up to Rs 2 Lakhs are as under:
The category-wise details of the Basis of Allotment for Employee above Rs 2 Lakhs and up to Rs 5 Lakhs are as under:
*Form part of 165 applicants who have bidded above Rs 2 Lakhs and up to Rs 5 Lakhs
D. Allotment to QIBs (excluding Anchor Investors and after technical rejection)
Allotment to QIBs, who have Bid at the Offer Price of Rs 248 per Equity Share or above, has been done on a proportionate basis in consultation with the NSE. This cetegory has been subscribed to the extent of 3.5624 times of QlB Portion. The total number of Equity Shares Allotted in the QIB Portion is 5,078,154 Equity Shares, which were allotted to 16 successful QIB Bidders. The category-wise details of the Basis of Allotment are as under.
Includes spillover of 1,031,386 Equity Shares from NIB Category
E. Allolment to Anchor I nvestors
The IPO Committee of our Company on December 13, 2017 has taken on record the Basis of Allotment of Equity Shares approved by the Designated Stock Exchange, being NSE and has allotted the Equity Shares to various successful Bidders. The Allotment Advice-cum-lntimations and/ or notices will be dispatched to the address of the investors as registered with the depositories. In case the same is not received, investors may contact the Registrar to the Offer at the address given below. The instructions to the Self Certified Syndicate Banks for unblocking of funds, transfer to Public Offer Account have been issued on December 13, 2017 and payment to non-Syndicate brokers have been issued on December 13, 2017. The Equity Shares Allotted to the successful Allottees have been uploaded by CDSL and by NSDL on December 13, 2017 for credit into the respective beneficiary accounts subject to validation of the account details with the depositories concerned. Our Company has filed the listing application with NSE and BSE on December 13, 2017. Our Company has received listing and trading approval from NSE and BSE and the trading will commence on or about December 15, 2017
All capitalised terms used and not specifically defined herein shall have the same meaning as ascribed to them in the Prospectus.
INVESTORS PLEASE NOTE
The details of the allotment made have been hosted on the website of the Registrar to the Offer, Karvy Computershare Private Limited at https://karisma.karvy.com
All future correspondence in this regard may kindly be addressed to the Registrar to the Offer quoting full name of the first/sole Bidders, Bid cum Application Form number, Bidder DP,ID, Client ID, PAN, date of submission of Bid cum Application Form, address of the Bidder, number of Equity Shares applied for, the name and address of the Designated Intermediary where the Bid cum Application form was submitted by Bidder and a Copy of the Acknowledgement Slip received from the Designated Intermediary at the address given below:
KARVY COMPUTERSHARE PRIVATE LIMITED
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF SHALBY LIMITED